Federated Hermes
KRRO icon

Federated Hermes’s Korro Bio KRRO Stock Holding History

Federated Hermes’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-302
Closed -$2.42K – 2117
2025
Q4 		$2.42K Buy
+302
New +$7.06K ﹤0.01% 1956
2025
Q2 		– Sell
-64
Closed -$1.11K – 2126
2025
Q1 		$1.11K Buy
+64
New +$1.9K ﹤0.01% 1992
2023
Q1 		– Sell
-26,232
Closed -$5.05M – 2198
2022
Q4 		$5.05M Sell
26,232
-248
-0.9% -$25.5K 0.01% 685
2022
Q3 		$2.37M Sell
26,480
-4,554
-15% -$462K 0.01% 871
2022
Q2 		$2.33M Sell
31,034
-28,327
-48% -$1.91M 0.01% 891
2022
Q1 		$6.29M Buy
59,361
+3,340
+6% +$638K 0.01% 724
2021
Q4 		$14.4M Buy
56,021
+4,571
+9% +$1.39M 0.03% 566
2021
Q3 		$18.2M Buy
51,450
+10,502
+26% +$4.13M 0.03% 494
2021
Q2 		$20.4M Sell
40,948
-23,300
-36% -$11.4M 0.04% 475
2021
Q1 		$30.5M Buy
64,248
+37,390
+139% +$72.6M 0.06% 387
2020
Q4 		$47.4M Sell
26,858
-400
-1% -$528K 0.1% 263
2020
Q3 		$26.2M Buy
27,258
+80
+0.3% +$85.9K 0.06% 355
2020
Q2 		$31.6M Sell
27,178
-1,157
-4% -$1.05M 0.08% 292
2020
Q1 		$25.2M Buy
28,335
+877
+3% +$947K 0.07% 292
2019
Q4 		$24.1M Buy
+27,458
New +$21.4M 0.05% 370

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes's KRRO Position: Q1 2026 in Review

Federated Hermes sold out of Korro Bio (KRRO) in Q1 2026, closing a stake of 302 shares — an estimated $2.42K sold.

Federated Hermes first reported a position in KRRO in Q4 2019 and held it in 15 quarters. The position peaked at $47.4M in Q4 2020. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Federated Hermes reported no remaining Korro Bio position as of Q1 2026 after selling out during the quarter.
  • Federated Hermes sold 302 Korro Bio shares in Q1 2026, an estimated $2.42K.
  • Federated Hermes first reported a position in Korro Bio in Q4 2019 and held it in 15 quarters.
  • Federated Hermes's Korro Bio position peaked at $47.4M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.